Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recepient?

Transplantation

Volumn 73, Issue 7, 2002, Pages 1158-1163

  Johnson, David W ^a   Nicol, David L ^a   Purdie, David M ^a   Preston, John M ^a   Brown, Allison M ^a   Hawley, Carmel M ^a   Campbell, Scott B ^a   Wall, Darryl ^a   Griffin, Anthony D ^a   Isbel, Nicole M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; VALACICLOVIR;

ADULT; AGED; ARTICLE; BLOOD DISEASE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OPPORTUNISTIC INFECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

EID: 0037090852     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200204150-00027     Document Type: Article

References (16)

1. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
3. Mycophenolate mofetil in cadaveric renal transplantation
4. Mycophenolate mofetil in renal transplantation: 3-Year results from the placebo-controlled trial
5. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years
6. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients
7. Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
8. Renal replacement therapies in the elderly: Part II. Renal transplantation
9. Renal transplantation in patients over sixty years of age
10. Transplantation in the elderly: A review
11. Outcome of renal transplantation in patients over the age of 60: A case-control study
12. Increased immunosuppressive vulnerability in elderly renal transplant recipients
13. Exponentially increased risk of infectious death in older renal transplant recipients
14. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients
15. Infectious complications in geriatric renal transplant patients: Comparison of two immunosuppressive protocols
16. Renal transplantation and the elderly